These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3070901)

  • 1. [Long-term results of radical prostatectomy].
    Grups JW
    Urologe A; 1988 Nov; 27(6):348-51. PubMed ID: 3070901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of 15 years of radical prostatectomy].
    Frohmüller H; Theiss M; Wirth M; Hofmockel G
    Urologe A; 1995 May; 34(3):225-30. PubMed ID: 7610518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radical prostatectomy in stage C prostatic cancer].
    Flamm J; Kiesswetter H
    Z Urol Nephrol; 1987 Mar; 80(3):185-9. PubMed ID: 3604476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term outcome of radical prostatectomy in an observation period of at least 10 years].
    Fischer C; Schreiber A; Altwein JE
    Aktuelle Urol; 2005 Apr; 36(2):131-5. PubMed ID: 15902573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.
    Ramos CG; Roehl KA; Antenor JA; Humphrey PA; Catalona WJ
    J Urol; 2004 Jul; 172(1):137-40. PubMed ID: 15201754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection criteria for radical prostatectomy with reference to long-term results].
    Frohmüller H; Wirth M; Manseck A; Theiss M
    Urologe A; 1991 Nov; 30(6):394-400. PubMed ID: 1771718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
    Pfitzenmaier J; Pahernik S; Tremmel T; Haferkamp A; Buse S; Hohenfellner M
    BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results after radical prostatectomy for prostate carcinoma].
    Studer UE; Peter HU; Kraft R; Zingg EJ
    Schweiz Med Wochenschr; 1986 Dec; 116(52):1834-40. PubMed ID: 3823816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
    Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H
    J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
    Carver BS; Bianco FJ; Scardino PT; Eastham JA
    J Urol; 2006 Aug; 176(2):564-8. PubMed ID: 16813890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
    Chuang AY; Nielsen ME; Hernandez DJ; Walsh PC; Epstein JI
    J Urol; 2007 Oct; 178(4 Pt 1):1306-10. PubMed ID: 17698141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: a single institutional study.
    Hachiya T; Okada Y; Kawata N; Hirano D; Yoshida T; Okada K; Takimoto Y
    Int J Urol; 2004 Oct; 11(10):862-9. PubMed ID: 15479291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity.
    Lerner SE; Blute ML; Zincke H
    J Urol; 1995 Oct; 154(4):1447-52. PubMed ID: 7658555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra- and postoperative morbidity of radical prostatectomy].
    Kleinschmidt K; Vieweg J; Gottfried HW; Miller K; Hautmann R
    Urologe A; 1991 Nov; 30(6):387-93. PubMed ID: 1771717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.
    Gjertson CK; Asher KP; Sclar JD; Goluboff ET; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Oct; 70(4):723-7. PubMed ID: 17991544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical results of radical prostatectomy for patients with prostate cancer in Macau.
    Ho SF; Lao HF; Li K; Tse MK
    Chin Med J (Engl); 2008 Feb; 121(4):295-8. PubMed ID: 18304459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.